Pesquisas alternativas:
safety one » safety zone (Expandir a Pesquisa), safety zones (Expandir a Pesquisa), safety over (Expandir a Pesquisa)
arm case » farm case (Expandir a Pesquisa), arm cause (Expandir a Pesquisa), arms case (Expandir a Pesquisa)
case 2 » case _ (Expandir a Pesquisa), case 1 (Expandir a Pesquisa)
safety one » safety zone (Expandir a Pesquisa), safety zones (Expandir a Pesquisa), safety over (Expandir a Pesquisa)
arm case » farm case (Expandir a Pesquisa), arm cause (Expandir a Pesquisa), arms case (Expandir a Pesquisa)
case 2 » case _ (Expandir a Pesquisa), case 1 (Expandir a Pesquisa)
201
Por Gray, Richard, Hillel, Stav A., Brown, Ellie, Al Ghareeb, Amal
Publicado no Methods Protoc (2018)
“... heterogeneity is detected (via χ(2) and I(2)), we will adopt the random effects model for computation....”Publicado no Methods Protoc (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
202
“... regimen can lead to graft rejection and loss. This study assessed the efficacy and safety of conversion...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
203
Por Takuji Kurimoto, Kaori Ueda, Sotaro Mori, Seiko Kamada, Mari Sakamoto, Yuko Yamada-Nakanishi, Wataru Matsumiya, Makoto Nakamura
Publicado em 2020-05-01
“... investigated the effectiveness and safety of skin electrical stimulation (SES) for cases of LHON harboring...”Publicado em 2020-05-01
Obter o texto integral
Artigo
204
“.... There were 251 patients in the intervention arm and 537 in the control arm. The two groups were similar...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
205
Por Stanga, Paulo E., Williams, Jon I., Shaarawy, Sherif A., Agarwal, Amar, Venkataraman, Anusha, Kumar, Dhivya A., You, Timothy T., Hope, Richard S.
Publicado no Retina (2020)
“...: Postapproval, prospective, single-arm, noncomparative, open-label study at one clinical site in India...”Publicado no Retina (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
206
Por Li, Ziyu, Ao, Sheng, Bu, Zhaode, Wu, Aiwen, Wu, Xiaojiang, Shan, Fei, Ji, Xin, Zhang, Yan, Xing, Zhaodong, Ji, Jiafu
Publicado no World J Surg Oncol (2016)
“... were randomly allocated to two subgroups. In the experimental group, 1.0 mL of CNP was injected...”Publicado no World J Surg Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
207
Por Amitabh, Vindu, Singhal, Anish, Kumar, Sudhir, Patel, Narmada, Rizvi, Yasir S., Mishra, Pankaj
Publicado em 2012
“... evaluated three times during the entire course of treatment (Visit 1, Day 0; Visit 2, Day 2-4; Visit 3, Day...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
208
Por Stanton, Cynthia K., Newton, Samuel, Mullany, Luke C., Cofie, Patience, Tawiah Agyemang, Charlotte, Adiibokah, Edward, Amenga-Etego, Seeba, Darcy, Niamh, Khan, Sadaf, Armbruster, Deborah, Gyapong, John, Owusu-Agyei, Seth
Publicado em 2013
“.... In oxytocin and control arms, respectively, PPH-1 rates were 2.6% versus 5.5% (RR: 0.49; 95% CI: 0.27–0.88...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
209
Por Gerber, David E., Swanson, Paul, Lopez-Chavez, Ariel, Wong, Lucas, Dowlati, Afshin, Pennell, Nathan A., Cronier, Damien M., Qin, Amy, Ilaria, Robert, Cosaert, Jan, Shahir, Ashwin, Baggstrom, Maria Q.
Publicado no Lung Cancer (2017)
“...% CI [0.68–1.57]; p=0.87). Both arms had similar toxicity profiles. All evaluable cases were PDGFR...”Publicado no Lung Cancer (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
210
Por Fujimaki, T., Itoh, K., Terasaki, M., Narita, Y., Arakawa, Y., Sugiyama, K., Nishikawa, R., Aoki, T., Kumabe, T., Nagane, M.
Publicado no Neuro Oncol (2017)
“..., excluding one case of pulmonary embolus. Overall survival of all cases (both vaccine and placebo arms...”Publicado no Neuro Oncol (2017)
Obter o texto integral
Obter o texto integral
Artigo
211
Por VINCENT, PJ, GARG, MK, SINGH, Y, BHALLA, VP, DATTA, SGS
Publicado no Med J Armed Forces India (2001)
“... ranged from 6 months to 4 years. 13 of 32 cases were males. Age ranged from 20 to 57 years. There was 1...”Publicado no Med J Armed Forces India (2001)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
212
“... managed at a tertiary eye hospital in the Eastern Province of Saudi Arabia. METHODS: This one-armed...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
213
Por Nywening, Timothy M, Wang-Gillam, Andrea, Sanford, Dominic E, Belt, Brian A, Panni, Roheena Z, Cusworth, Brian M, Toriola, Adetunji T, Nieman, Rebecca K, Worley, Lori A, Yano, Motoyo, Fowler, Kathryn J, Lockhart, A Craig, Suresh, Rama, Tan, Benjamin R, Lim, Kian-Huat, Fields, Ryan C, Strasberg, Steven M, Hawkins, William G, DeNardo, David G, Goedegebuure, S Peter, Linehan, David C
Publicado no Lancet Oncol (2016)
“...%), anemia in 2 cases (33%), lymphopenia in 1 cases (17%), diarrhea in 2 cases (33%), hypoalbuminemia in 1...”Publicado no Lancet Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
214
Por Takeuchi, Tsutomu, Yamanaka, Hisashi, Harigai, Masayoshi, Tamamura, Ryo, Kato, Yuichi, Ukyo, Yoshifumi, Nakano, Toshikazu, Hsu, Benjamin, Tanaka, Yoshiya
Publicado no Arthritis Res Ther (2018)
“... and phase 2 studies. The present study evaluated the safety and efficacy of sirukumab, as monotherapy...”Publicado no Arthritis Res Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
215
Por Kumar, Hemant, Ha, Doo-Hoe, Lee, Eun-Jong, Park, Jun Hee, Shim, Jeong Hyun, Ahn, Tae-Keun, Kim, Kyoung-Tae, Ropper, Alexander E., Sohn, Seil, Kim, Chung-Hun, Thakor, Devang Kashyap, Lee, Soo-Hong, Han, In-Bo
Publicado no Stem Cell Res Ther (2017)
“... in patients with chronic discogenic LBP. METHODS: We performed a single-arm phase I clinical trial with a 12...”Publicado no Stem Cell Res Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
216
“... in one month was 86.84% (33/38), while the dyspnea index significantly decreased from 4.11 ± 1.11 to 2...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
217
Por Cohen, Stephanie, Sekigami, Yurie, Schwartz, Theresa, Losken, Albert, Margenthaler, Julie, Chatterjee, Abhishek
Publicado no Gland Surg (2019)
“... and there was a statistically significant difference in Her-2 positive cancers in the study arms of two articles...”Publicado no Gland Surg (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
218
Por Boszczyk, Bronek M., Bierschneider, Michael, Panzer, Stephanie, Panzer, Werner, Harstall, Roger, Schmid, Katharina, Jaksche, Hans
Publicado em 2005
“... level cases reached 2.2 min (range 0.6–4.3) in the lateral plane and 1.6 min (range 0.5–3.0...”Publicado em 2005
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
219
Por Chen, Zhiwei, Shen, Shengping, Shi, Wenbo, Jiang, Gening, Wang, Xin, Jian, Hong, Zhou, Zhen, Ding, Zhengping, Lu, Shun
Publicado no Cancer Manag Res (2019)
“... with wild-type EGFR (n=9) (85.71% vs 55.56%, P=0.00). Most AEs were CTCAE grade 1 or 2; there were no cases...”Publicado no Cancer Manag Res (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
220